MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-PY-03-0000552
Biogenomics Limited - pharma in Puducherry, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹13.42 Cr
▲ 25.48% YoY
Net loss · FY 2024
₹24 Cr
Net margin -178.8%
EBITDA · FY 2024
-₹26.37 Cr
EBITDA margin -196.5%
Authorised capital
₹390.02 Cr
Registered with MCA
Paid-up capital
₹383.51 Cr
Issued & subscribed
Open charges
₹3.98 Cr
Satisfied ₹8.7 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
254
Provident fund records
About Biogenomics Limited
Data last updated:
Biogenomics Limited is a public limited company based in Puducherry, India, a subsidiary of Mb Holdings Mauritius Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24234PY2002PLC009158. Its GSTIN is 34AABCB7979D1ZL (Puducherry). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹390.02 Cr and a paid-up capital of ₹383.51 Cr. It was formerly known as Biogenomics Private Limited. It is led by directors including Archana Rajesh Krishnan (Whole-Time Director) and Rajesh Shashikant Dalal.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R. S. No. 139 Manapet Road Kanniakoil Manapet Village, Bahour Commune Pondicherry, Puducherry, India – 607402.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.42 Cr. For the same year it recorded a net loss of ₹24 Cr (net margin -178.8%) and EBITDA of -₹26.37 Cr (EBITDA margin -196.5%).
The company has about 254 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: AuriSignum and BioGenomics. As per MCA filings, the company has open charges of ₹3.98 Cr and satisfied charges of ₹8.7 Cr on record. Court records list 7 cases involving the company, including 7 filed against it. The company has 10 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹379.18 Cr; the latest was in May 2022. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Embellish Pharma Tech Private Limited with revenue of ₹10.72 Cr. The company has 9 MSME Form 1 returns on record between 2020 and 2024, listing 89 overdue payments to 26 micro and small suppliers.
Biogenomics Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0000552). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biogenomics.co.in.
Company details
CIN U24234PY2002PLC009158
Registration Number 009158
Incorporation Date 24 April 2002
ROC Pondicherry
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Mb Holdings Mauritius Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PY-03-0000552
CIN history
Biogenomics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24234PY2002PLC009158, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24234PY2002PLC009158 | Current |
| L24234TN2002PLC048821 | Previous |
| U24234TN2002PLC048821 | Previous |
Key People
Archana Rajesh Krishnan Whole-Time Director Pushkar Jauhari Nominee Director Rajesh Shashikant Dalal Director Recognitions & Rankings of Biogenomics
Contact details
Biogenomics Limited's registered office is in Puducherry, Puducherry. Its website is biogenomics.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressR. S. No. 139 Manapet Road Kanniakoil Manapet Village, Bahour Commune Pondicherry, Puducherry, India – 607402
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biogenomics Limited, buy the company report.
Comprehensive company report
Biogenomics Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Biogenomics operates two associated brands: AuriSignum and BioGenomics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers characterization services for biopharmaceuticals including proteins and antibodies. | aurisignum.com | |
| Recombinant DNA-based biosimilars, proteins, and enzymes are developed. | biogenomics.co.in |
Business activity
The main business activity of Biogenomics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Biogenomics Limited, buy the company report.
Financials of Biogenomics Limited
FY 2025 filings availableBiogenomics Limited reported revenue of ₹13.42 Cr for FY 2024.
Revenue · FY 2024
₹13.42 Cr
Net loss · FY 2024
₹24 Cr margin -178.8%
EBITDA · FY 2024
-₹26.37 Cr margin -196.5%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹13.42 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹26.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -196.5% | ||||
| Net Profit Margin | -178.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biogenomics Limited, buy the company report.
Board of directors of Biogenomics Limited
Biogenomics has 9 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushkar Jauhari | Nominee Director | 19 Jun 2022 | 4 Years 4 Months | Current |
| Rajesh Shashikant Dalal | Director | 08 Dec 2023 | 2 Years 11 Months | Current |
| Rajiv Malik | Additional Director | 01 Jul 2025 | 1 Years 4 Months | Current |
| Namit Rustagi | Director | 28 Mar 2022 | 4 Years 7 Months | Current |
| Ammar Abdullah Hamad Al Ali | Director | 28 Mar 2022 | 4 Years 7 Months | Current |
| Archana Rajesh Krishnan Also directs: Reflex Technologies Private Limited | Whole-Time Director | 03 Feb 2006 | 20 Years 9 Months | Current |
Showing 6 of 9 current directors. View all directors
Peer comparison
Biogenomics Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biogenomics Limitedthis company | ₹13.42 Cr (FY 2024) | -₹24 Cr | -178.8% | 254 | Puducherry, India | |
| Embellish Pharma Tech Private Limited | ₹10.72 Cr (FY 2025) | 10.0% | Roorkee, Uttarakhand, India | |||
| Elite Pharma Private Limited | ₹10.71 Cr (FY 2025) | 3.0% | Ahmedabad, Gujarat, India | |||
| Medioint Lifescience Private Limited | ₹10.68 Cr (FY 2025) | -1.0% | Dhar, Madhya Pradesh, India |
To see the full peer comparison of Biogenomics Limited, buy the company report.
Auditor
Biogenomics Limited is audited by S R B C & CO LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2024 | E300003 |
Shareholding
The shareholding of Biogenomics Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biogenomics Limited, buy the company report.
Charges & borrowings
Open charges
₹3.98 Cr
Satisfied charges
₹8.7 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2024 | 100902481 | Standard Chartered Bank | ₹3.98 Cr | Satisfied | |
| 11 Jan 2014 | 10470587 | Icici Bank Limited | ₹3.6 Cr | Satisfied | |
| 10 Oct 2003 | 90295025 | U.C.O. Bank | ₹1.12 Cr | Satisfied |
To see the full charge records of Biogenomics Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Biogenomics Limited has 10 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹379.18 Cr; the latest was in May 2022.
Total deals
10
Funding rounds
5
Secondary share transfers
3
Rights issues
2
Disclosed funding
₹379.18 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Funding round | ₹164.13 Cr | Investors: Eagle Asia Holdings Limited |
| Mar 2022 | Funding round | ₹95.01 Cr | Investors: Mohammed Al Barwani Investment LLC |
| Jan 2022 | Funding round | ₹18.4 Cr | Investors: Eagle Asia Holdings Limited |
| Dec 2021 | Funding round | ₹91.27 Cr | Investors: Mb Holding Mauritius Limited |
| Nov 2020 | Rights issue | ₹6.03 Cr | Investors: Mb Holding Mauritius Limited, 2 individuals |
To see the full deal history of Biogenomics Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biogenomics Limited has 7 court cases on record: 7 filed against it. All cases are disposed.
Total cases
7
Filed against the company
7
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by The State of Gujarat | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR-EN) | Filed against the company by The State of Gujarat | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company | Disposed |
| District court, Kolhapur, Maharashtra | Civil suit | Filed against the company by individuals | Disposed |
To see the full case history of Biogenomics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Biogenomics Limited has 9 MSME Form 1 returns on record between 2020 and 2024, listing 89 overdue payments to 26 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 26)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| VGN Buildcon | |||
| Tamarind Global Services Private Limited | |||
| Tamilnadu Test House Private Limited |
To see the full MSME payment records of Biogenomics Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Biogenomics Limited has a workforce of 254 employees on its EPFO records as of Mar 2026, across 2 active EPFO establishments.
Employee count
254
Active EPFO establishments
2
Employee growth
21%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 254 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Biogenomics Limited, buy the company report.
GST
Biogenomics has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AABCB7979D1ZL | Puducherry | Active | 01 Jul 2017 |
| 27AABCB7979D1ZG | Maharashtra | Active | 01 Jul 2017 |
| 27AABCB7979D2ZF | Maharashtra | Active | 01 Jul 2017 |
| 24AABCB7979D1ZM | Gujarat | Active | 12 Apr 2023 |
To see the full GST registrations and return filing status of Biogenomics Limited, buy the company report.
Recent activity
Biogenomics Limited has 31 board changes on record since 2006: 11 appointments and 20 cessations. The latest: Rajiv Malik was appointed as Additional Director on 01 Jul 2025.
AGM
Biogenomics Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Charges
A charge registered on 21 Mar 2024 via Charge ID 100902481 with Standard Chartered Bank was fully satisfied on 20 Aug 2025.
Appointed
Rajiv Malik was appointed as Additional Director.
Filing
Biogenomics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pondicherry.
Ceased
Imran Jamiluddin Shaikh ceased to be Additional Director.
Appointed
Imran Jamiluddin Shaikh was appointed as Nominee Director.
Ceased
Rajesh Shashikant Dalal ceased to be Additional Director.
Charges
A charge with Standard Chartered Bank amounted to Rs. 3.98 Cr with Charge ID 100902481 was registered on 21 Mar 2024.
Appointed
Rajesh Shashikant Dalal was appointed as Director.
Appointed
Sanjay Madhukar Sonar was appointed as Manager.
Ceased
Ali Abdullah Ali Al Aamri ceased to be Additional Director.
Ceased
Ibrahim Saud Said Al Zakwani ceased to be Additional Director.
29 earlier events are in the company report.
Frequently asked questions
Biogenomics is an active public limited company based in Puducherry, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2002 (24+ years old) and is registered under CIN U24234PY2002PLC009158.
Biogenomics has 9 current directors:
- Archana Rajesh Krishnan - Whole-Time Director
- Pushkar Jauhari - Nominee Director
- Rajesh Shashikant Dalal - Director
- Rajiv Malik - Additional Director
- Namit Rustagi - Director
- Ammar Abdullah Hamad Al Ali - Director
- Imran Jamiluddin Shaikh - Nominee Director
- Ali Abdullah Ali Al Aamri - Nominee Director
- Mohammed Hamdan Saif Al Rubaie - Nominee Director
The latest financial statements of Biogenomics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biogenomics is 34AABCB7979D1ZL, registered in Puducherry. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AABCB7979D1ZG (Maharashtra), 27AABCB7979D2ZF (Maharashtra), 24AABCB7979D1ZM (Gujarat).
The CIN (Corporate Identification Number) of Biogenomics is U24234PY2002PLC009158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biogenomics has 7 court cases on record: 7 filed against it.
Biogenomics was incorporated on 24 April 2002, making it 24+ years old. It is registered with the Registrar of Companies, Pondicherry.
Biogenomics has 10 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹379.18 Cr; the latest was in May 2022.
The peers of Biogenomics by revenue are Embellish Pharma Tech Private Limited, Elite Pharma Private Limited, Medioint Lifescience Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajiv Malik was appointed as Additional Director on 01 Jul 2025. Imran Jamiluddin Shaikh ceased to be Additional Director on 23 Sep 2024. Imran Jamiluddin Shaikh was appointed as Nominee Director on 20 Aug 2024. Biogenomics has 31 board changes on record in total.
Yes, Biogenomics is registered as a small enterprise under Udyam registration (number: UDYAM-PY-03-0000552).
Biogenomics has 9 MSME Form 1 returns on record between 2020 and 2024, listing 89 overdue payments to 26 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages